Presentation is loading. Please wait.

Presentation is loading. Please wait.

The walking impairment questionnaire: An effective tool to assess the effect of treatment in patients with intermittent claudication  Saskia P.A. Nicolaï,

Published byÉmilien Ringuette Modified over 5 years ago

Similar presentations

Presentation on theme: "The walking impairment questionnaire: An effective tool to assess the effect of treatment in patients with intermittent claudication  Saskia P.A. Nicolaï,"— Presentation transcript:

1 The walking impairment questionnaire: An effective tool to assess the effect of treatment in patients with intermittent claudication  Saskia P.A. Nicolaï, MD, Lotte M. Kruidenier, MD, Ellen V. Rouwet, MD, PhD, Kirsten Graffius, Martin H. Prins, MD, PhD, Joep A.W. Teijink, MD, PhD  Journal of Vascular Surgery  Volume 50, Issue 1, Pages (July 2009) DOI: /j.jvs Copyright © 2009 Society for Vascular Surgery Terms and Conditions

2 Fig Change in Walking Impairment Questionnaire (WIQ) compared to the change in absolute claudication distance 3 months after treatment of intermittent claudication. Journal of Vascular Surgery  , 89-94DOI: ( /j.jvs ) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Download ppt "The walking impairment questionnaire: An effective tool to assess the effect of treatment in patients with intermittent claudication  Saskia P.A. Nicolaï,"

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages 1072-1082 (October 2014) DOI:

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:
I may not be Southern by birth, but I am proud to be an American: The role of international medical graduates in vascular surgery and the Southern Association.

I may not be Southern by birth, but I am proud to be an American: The role of international medical graduates in vascular surgery and the Southern Association.
Andrew W. Gardner, PhD, Donald E. Parker, PhD, Polly S

Andrew W. Gardner, PhD, Donald E. Parker, PhD, Polly S
Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease  Samuel R. Money, MD, J.Alan.

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease  Samuel R. Money, MD, J.Alan.
Without prejudice Journal of Vascular Surgery

Without prejudice Journal of Vascular Surgery
Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication  Saskia.

Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication  Saskia.
Saskia P. A. Nicolaï, MD, Wolfgang Viechtbauer, MS, PhD, Lotte M

Saskia P. A. Nicolaï, MD, Wolfgang Viechtbauer, MS, PhD, Lotte M
Revenue cycle management

Revenue cycle management
Lotte M. Kruidenier, MD, Saskia P. Nicolaï, MD, Erik J

Lotte M. Kruidenier, MD, Saskia P. Nicolaï, MD, Erik J
The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves.

The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves.
Validation of a new simple questionnaire to “estimate ambulation capacity by history” (EACH) in patients with claudication  Nafi Ouedraogo, MD, Guillaume.

Validation of a new simple questionnaire to “estimate ambulation capacity by history” (EACH) in patients with claudication  Nafi Ouedraogo, MD, Guillaume.
Lindy N. M. Gommans, MD, Marc R. M. Scheltinga, MD, PhD, Marc R. H. M

Lindy N. M. Gommans, MD, Marc R. M. Scheltinga, MD, PhD, Marc R. H. M
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr

Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr
Mohamed A. Zayed, MD, PhD, Ronald L. Dalman, MD, Jason T. Lee, MD 

Mohamed A. Zayed, MD, PhD, Ronald L. Dalman, MD, Jason T. Lee, MD 
Mesenteric venous thrombosis with transmural intestinal infarction: A population-based study  Stefan Acosta, MD, PhD, Mats Ögren, MD, PhD, Nils-Herman.

Mesenteric venous thrombosis with transmural intestinal infarction: A population-based study  Stefan Acosta, MD, PhD, Mats Ögren, MD, PhD, Nils-Herman.
Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 

Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 
Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)  William R. Hiatt,
The first operation on the profunda femoris artery

The first operation on the profunda femoris artery
Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease  Samuel R. Money, MD, J.Alan.

Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease  Samuel R. Money, MD, J.Alan.

Similar presentations

Ads by Google